Skip to content

ofb008

Seminar

Response-adaptive dose-finding under model uncertainty

Bretz, F (Novartis)
Tuesday 16 August 2011, 14:00-14:30

Seminar Room 1, Newton Institute

Abstract

In pharmaceutical drug development, dose-finding studies are of critical importance because both safety and clinically relevant efficacy have to be demonstrated for a specific dose of a new compound before market authorization. Motivated by a real dose-finding study, we propose response-adaptive designs addressing two major challenges in dose-finding studies: uncertainty about the dose-response models and large variability in parameter estimates. To allocate new cohorts of patients in an ongoing study, we use optimal designs that are robust under model uncertainty. In addition, we use a Bayesian shrinkage approach to stabilize the parameter estimates over the successive interim analyses used in the adaptations. This approach allows us to calculate updated parameter estimates and model probabilities that can then be used to calculate the optimal design for subsequent cohorts. The resulting designs are hence robust with respect to model misspecification and additionally can ef ficiently adapt to the information accrued in an ongoing study. We focus on adaptive designs for estimating the minimum effective dose, although alternative optimality criteria or mixtures thereof could be used, enabling the design to address multiple objectives. In an extensive simulation study, we investigate the operating characteristics of the proposed method under a variety of scenarios.

Presentation

[pdf]

Video

Your browser canít play this video. You do not appear to have a flash player installed.
Please download flash player or choose an alternative format instead.

Get Adobe Flash player

Available Video Formats

Back to top ∧